Clinical Trials Logo

Schizo Affective Disorder clinical trials

View clinical trials related to Schizo Affective Disorder.

Filter by:
  • Suspended  
  • Page 1

NCT ID: NCT05046353 Suspended - Schizophrenia Clinical Trials

D-serine AudRem: R33 Phase

Start date: December 1, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

Schizophrenia is a major public health problem associated with cognitive deficits, such as short and long term memory, executive functioning, attention and speed of processing that are amongst the strongest predictors of impaired functional outcome. In addition, schizophrenia patients show reduced "plasticity", defined as reduced learning. D-serine is a naturally occurring activator of the N-methyl-d-aspartate-type glutamate receptors (NMDAR) in the brain, and this project will assess the D-serine treatment over 16 weeks of a program designed to measure auditory plasticity.